{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T04:13:03Z","timestamp":1794975183892,"version":"4.9.1"},"reference-count":221,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience &amp; Biobehavioral Reviews"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.neubiorev.2025.106218","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T23:10:05Z","timestamp":1747782605000},"page":"106218","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["Insulin resistance: The role in comorbid type 2 diabetes mellitus and depression"],"prefix":"10.1016","volume":"175","author":[{"given":"Jia","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-qing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-wen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-hua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-min","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-jian","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-mei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neubiorev.2025.106218_bib1","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.jad.2018.11.090","article-title":"Double-blind, placebo-controlled trial of pioglitazone for bipolar depression","volume":"245","author":"Aftab","year":"2019","journal-title":"J. Affect Disord."},{"issue":"6","key":"10.1016\/j.neubiorev.2025.106218_bib2","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/jphp.12213","article-title":"Bupropion effects on high-fat diet-induced steatohepatitis and endothelial dysfunction in rats: role of tumour necrosis factor-alpha","volume":"66","author":"Ahmed","year":"2014","journal-title":"J. Pharm. Pharm."},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106218_bib3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3390\/biomedicines11030860","article-title":"Rosiglitazone Mitigates Dexamethasone-Induced Depression in Mice via Modulating Brain Glucose Metabolism and AMPK\/mTOR Signaling Pathway","volume":"11","author":"Alhaddad","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.neubiorev.2025.106218_bib4","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jad.2023.03.072","article-title":"The physio-affective phenome of major depression is strongly associated with biomarkers of astroglial and neuronal projection toxicity which in turn are associated with peripheral inflammation, insulin resistance and lowered calcium","volume":"331","author":"Al-Hakeim","year":"2023","journal-title":"J. Affect Disord."},{"issue":"6","key":"10.1016\/j.neubiorev.2025.106218_bib5","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.2337\/diacare.24.6.1069","article-title":"The prevalence of comorbid depression in adults with diabetes: a meta-analysis","volume":"24","author":"Anderson","year":"2001","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106218_bib6","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrneurol.2017.185","article-title":"Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums","volume":"14","author":"Arnold","year":"2018","journal-title":"Nat. Rev. Neurol."},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106218_bib7","doi-asserted-by":"crossref","first-page":"102","DOI":"10.5414\/CP204288","article-title":"Metformin alone and in combination with sitagliptin induces depression and impairs quality of life in type 2 diabetes mellitus patients: An observational study","volume":"61","author":"Athar","year":"2023","journal-title":"Int J. Clin. Pharm. Ther."},{"issue":"10103","key":"10.1016\/j.neubiorev.2025.106218_bib8","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/S0140-6736(17)31585-4","article-title":"Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial","volume":"390","author":"Athauda","year":"2017","journal-title":"Lancet (Lond., Engl. )"},{"key":"10.1016\/j.neubiorev.2025.106218_bib9","doi-asserted-by":"crossref","DOI":"10.1017\/neu.2025.4","article-title":"Association of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and neurogenesis: a systematic review","volume":"37","author":"Au","year":"2025","journal-title":"Acta Neuropsychiatr."},{"issue":"11","key":"10.1016\/j.neubiorev.2025.106218_bib10","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-020062","article-title":"The association between insulin therapy and depression in patients with type 2 diabetes mellitus: a meta-analysis","volume":"8","author":"Bai","year":"2018","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106218_bib11","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.pharmthera.2012.07.006","article-title":"Insulin in the brain: there and back again","volume":"136","author":"Banks","year":"2012","journal-title":"Pharm. Ther."},{"key":"10.1016\/j.neubiorev.2025.106218_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2025.111258","article-title":"Unraveling the genetic links between depression and type 2 diabetes","volume":"137","author":"Baranova","year":"2025","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2025.106218_bib13","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1146\/annurev.ph.49.030187.002003","article-title":"Insulin in the brain","volume":"49","author":"Baskin","year":"1987","journal-title":"Annu Rev. Physiol."},{"key":"10.1016\/j.neubiorev.2025.106218_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1128387","article-title":"The potential antidepressant effect of antidiabetic agents: New insights from a pharmacovigilance study based on data from the reporting system databases FAERS and VigiBase","volume":"14","author":"Battini","year":"2023","journal-title":"Front Pharm."},{"key":"10.1016\/j.neubiorev.2025.106218_bib15","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/164760","article-title":"Comorbidity between Type 2 Diabetes and Depression in the Adult Population: Directions of the Association and Its Possible Pathophysiological Mechanisms","volume":"2015","author":"Berge","year":"2015","journal-title":"Int J. Endocrinol."},{"key":"10.1016\/j.neubiorev.2025.106218_bib16","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3389\/fendo.2014.00161","article-title":"Insulin in the brain: its pathophysiological implications for States related with central insulin resistance, type 2 diabetes and Alzheimer's disease","volume":"5","author":"Bl\u00e1zquez","year":"2014","journal-title":"Front Endocrinol. (Lausanne)"},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106218_bib17","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/13651500600645612","article-title":"Dual serotonin and noradrenaline reuptake inhibitors: Focus on their differences","volume":"10","author":"Blier","year":"2006","journal-title":"Int J. Psychiatry Clin. Pr."},{"key":"10.1016\/j.neubiorev.2025.106218_bib18","first-page":"1","article-title":"Empagliflozin ameliorates olfactory bulbectomy-induced depression by mitigating oxidative stress and possible involvement of brain derived neurotrophic factor in diabetic rats","author":"Borikar","year":"2024","journal-title":"Int J. Neurosci."},{"issue":"14","key":"10.1016\/j.neubiorev.2025.106218_bib19","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.2174\/138161209788168056","article-title":"Melatonin receptor agonist agomelatine: a new drug for treating unipolar depression","volume":"15","author":"Bourin","year":"2009","journal-title":"Curr. Pharm. Des."},{"issue":"12","key":"10.1016\/j.neubiorev.2025.106218_bib20","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/0026-0495(95)90077-2","article-title":"Long-term effects of fluoxetine on glycemic control in obese patients with non-insulin-dependent diabetes mellitus or glucose intolerance: influence on muscle glycogen synthase and insulin receptor kinase activity","volume":"44","author":"Breum","year":"1995","journal-title":"Metab.: Clin. Exp."},{"key":"10.1016\/j.neubiorev.2025.106218_bib21","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.jad.2021.08.151","article-title":"Insulin resistance as a marker for the immune-metabolic subtype of depression","volume":"295","author":"Brouwer","year":"2021","journal-title":"J. Affect Disord."},{"issue":"6865","key":"10.1016\/j.neubiorev.2025.106218_bib22","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/414813a","article-title":"Biochemistry and molecular cell biology of diabetic complications","volume":"414","author":"Brownlee","year":"2001","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.neubiorev.2025.106218_bib23","doi-asserted-by":"crossref","first-page":"E920","DOI":"10.1152\/ajpendo.00606.2009","article-title":"Treatment with an SSRI antidepressant restores hippocampo-hypothalamic corticosteroid feedback and reverses insulin resistance in low-birth-weight rats","volume":"298","author":"Buhl","year":"2010","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.neubiorev.2025.106218_bib24","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1172\/JCI99366","article-title":"Insulin regulates astrocyte gliotransmission and modulates behavior","volume":"128","author":"Cai","year":"2018","journal-title":"J. Clin. Investig."},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106218_bib25","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.21m14022","article-title":"Treating Insulin Resistance With Metformin as a Strategy to Improve Clinical Outcomes in Treatment-Resistant Bipolar Depression (the TRIO-BD Study): A Randomized, Quadruple-Masked, Placebo-Controlled Clinical Trial","volume":"83","author":"Calkin","year":"2022","journal-title":"J. Clin. Psychiatry"},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106218_bib26","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1192\/bjp.bp.114.152850","article-title":"Insulin resistance and outcome in bipolar disorder","volume":"206","author":"Calkin","year":"2015","journal-title":"Br. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106218_bib27","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1211\/jpp.59.1.0013","article-title":"Shifts in metabolic parameters surrounding glucose homoeostasis resulting from tricyclic antidepressant therapy: implications of insulin resistance?","volume":"59","author":"Chadwick","year":"2007","journal-title":"J. Pharm. Pharm."},{"key":"10.1016\/j.neubiorev.2025.106218_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2020.109872","article-title":"The GLP-1 receptor agonist liraglutide reverses mania-like alterations and memory deficits induced by D-amphetamine and augments lithium effects in mice: Relevance for bipolar disorder","volume":"99","author":"Chaves Filho","year":"2020","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"Pt C","key":"10.1016\/j.neubiorev.2025.106218_bib29","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.pnpbp.2017.04.035","article-title":"IDO chronic immune activation and tryptophan metabolic pathway: A potential pathophysiological link between depression and obesity","volume":"80","author":"Chaves Filho","year":"2018","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"6","key":"10.1016\/j.neubiorev.2025.106218_bib30","first-page":"723","article-title":"Contribution of neural cell death to depressive phenotypes of streptozotocin-induced diabetic mice","volume":"7","author":"Chen","year":"2014","journal-title":"Dis. Model Mech."},{"issue":"5","key":"10.1016\/j.neubiorev.2025.106218_bib31","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.tins.2022.03.001","article-title":"Insulin action in the brain: cell types, circuits, and diseases","volume":"45","author":"Chen","year":"2022","journal-title":"Trends Neurosci."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106218_bib32","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jagp.2023.08.010","article-title":"The Antidepressant Effects of GLP-1 Receptor Agonists: A Systematic Review and Meta-Analysis","volume":"32","author":"Chen","year":"2024","journal-title":"Am. J. Geriatr. Psychiatry"},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106218_bib33","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/MNM.0000000000001511","article-title":"The relationship between brain glucose metabolism and insulin resistance in subjects with normal cognition - a study based on 18F-FDG PET","volume":"43","author":"Chen","year":"2022","journal-title":"Nucl. Med Commun."},{"issue":"6","key":"10.1016\/j.neubiorev.2025.106218_bib34","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/mp.2014.136","article-title":"Neurotrophic factor-\u03b11 prevents stress-induced depression through enhancement of neurogenesis and is activated by rosiglitazone","volume":"20","author":"Cheng","year":"2015","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2025.106218_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111848","article-title":"Fluoxetine ameliorates high-fat diet-induced metabolic abnormalities partially via reduced adipose triglyceride lipase-mediated adipocyte lipolysis","volume":"141","author":"Chiu","year":"2021","journal-title":"Biomed. Pharm."},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106218_bib36","doi-asserted-by":"crossref","first-page":"370","DOI":"10.14310\/horm.2002.1600","article-title":"The efficacy and safety of the naltrexone\/bupropion combination for the treatment of obesity: an update","volume":"14","author":"Christou","year":"2015","journal-title":"Horm. (Athens)"},{"issue":"5","key":"10.1016\/j.neubiorev.2025.106218_bib37","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1080\/10799893.2022.2032747","article-title":"GLP-1 agonist liraglutide improves ouabain-induced mania and depressive state via GSK-3\u03b2 pathway","volume":"42","author":"\u00c7i\u00e7ekli","year":"2022","journal-title":"J. Recept Signal Transduct. Res"},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106218_bib38","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/01.PSY.0000041624.96580.1F","article-title":"Depression and coronary heart disease in women with diabetes","volume":"65","author":"Clouse","year":"2003","journal-title":"Psychosom. Med"},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106218_bib39","first-page":"49","article-title":"PPAR-\u03b3 Agonists for the Treatment of Major Depression: A Review","volume":"50","author":"Colle","year":"2017","journal-title":"Pharmacopsychiatry"},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106218_bib40","article-title":"Oxidative Stress in Depression: The Link with the Stress Response, Neuroinflammation, Serotonin, Neurogenesis and Synaptic Plasticity","volume":"12","author":"Correia","year":"2023","journal-title":"Antioxid. (Basel)"},{"issue":"10","key":"10.1016\/j.neubiorev.2025.106218_bib41","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nrn3346","article-title":"Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour","volume":"13","author":"Cryan","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"issue":"7","key":"10.1016\/j.neubiorev.2025.106218_bib42","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.2337\/db13-1954","article-title":"Inflammation, defective insulin signaling, and mitochondrial dysfunction as common molecular denominators connecting type 2 diabetes to Alzheimer disease","volume":"63","author":"De Felice","year":"2014","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106218_bib43","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/pds.1562","article-title":"The association between antidepressant use and hypoglycaemia in diabetic patients: a nested case-control study","volume":"17","author":"Derijks","year":"2008","journal-title":"Pharmacoepidemiol Drug Saf."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106218_bib44","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/YCO.0b013e32835a4206","article-title":"Effects of antidepressants on glucose metabolism and diabetes mellitus type 2 in adults","volume":"26","author":"Deuschle","year":"2013","journal-title":"Curr. Opin. Psychiatry"},{"issue":"1-2","key":"10.1016\/j.neubiorev.2025.106218_bib45","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0167-0115(93)90335-6","article-title":"Insulin II gene expression in rat central nervous system","volume":"48","author":"Devaskar","year":"1993","journal-title":"Regul. Pept."},{"key":"10.1016\/j.neubiorev.2025.106218_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113445","article-title":"The melatonergic agonist agomelatine ameliorates high fat diet-induced obesity in mice through the modulation of the gut microbiome","volume":"153","author":"Diez-Echave","year":"2022","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.neubiorev.2025.106218_bib47","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jpsychires.2023.01.037","article-title":"Shared genetics of psychiatric disorders and type 2 diabetes:a large-scale genome-wide cross-trait analysis","volume":"159","author":"Ding","year":"2023","journal-title":"J. Psychiatr. Res"},{"key":"10.1016\/j.neubiorev.2025.106218_bib48","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.euroneuro.2022.09.002","article-title":"The role of metformin as a treatment for neuropsychiatric illness","volume":"64","author":"Dodd","year":"2022","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neubiorev.2025.106218_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2023.114448","article-title":"Dapagliflozin inhibits the activity of lateral habenula to alleviate diabetes mellitus-induced depressive-like behavior","volume":"366","author":"Dong","year":"2023","journal-title":"Exp. Neurol."},{"issue":"12","key":"10.1016\/j.neubiorev.2025.106218_bib50","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.biopsych.2006.02.013","article-title":"A neurotrophic model for stress-related mood disorders","volume":"59","author":"Duman","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2025.106218_bib51","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.neuroscience.2016.03.056","article-title":"The role of Insulin-Like Growth Factor 1 (IGF-1) in brain development, maturation and neuroplasticity","volume":"325","author":"Dyer","year":"2016","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106218_bib52","doi-asserted-by":"crossref","first-page":"464","DOI":"10.2337\/diacare.25.3.464","article-title":"Comorbid depression is associated with increased health care use and expenditures in individuals with diabetes","volume":"25","author":"Egede","year":"2002","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.neubiorev.2025.106218_bib53","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.2174\/0929867327666200908114902","article-title":"Metformin: A Growing Journey from Glycemic Control to the Treatment of Alzheimer's Disease and Depression","volume":"28","author":"El Massry","year":"2021","journal-title":"Curr. Med Chem."},{"issue":"7","key":"10.1016\/j.neubiorev.2025.106218_bib54","first-page":"667","article-title":"Different effects of the antidepressant drugs imipramine, maprotiline and bupropion on insulin secretion from mouse pancreatic islets","volume":"46","author":"el-Dakhakhny","year":"1996","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.neubiorev.2025.106218_bib55","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.brainresbull.2018.01.001","article-title":"ATP-sensitive potassium-channel inhibitor glibenclamide attenuates HPA axis hyperactivity, depression- and anxiety-related symptoms in a rat model of Alzheimer's disease","volume":"137","author":"Esmaeili","year":"2018","journal-title":"Brain Res Bull."},{"key":"10.1016\/j.neubiorev.2025.106218_bib56","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3389\/fpsyt.2019.00057","article-title":"Insulin Resistance as a Shared Pathogenic Mechanism Between Depression and Type 2 Diabetes","volume":"10","author":"Esnm","year":"2019","journal-title":"Front Psychiatry"},{"issue":"5","key":"10.1016\/j.neubiorev.2025.106218_bib57","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.dsx.2020.06.021","article-title":"Antidepressant activity of anti-hyperglycemic agents in experimental models: A review","volume":"14","author":"Essmat","year":"2020","journal-title":"Diabetes Metab. Syndr. Sep-Oct."},{"key":"10.1016\/j.neubiorev.2025.106218_bib58","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jad.2019.09.013","article-title":"Metformin ameliorates stress-induced depression-like behaviors via enhancing the expression of BDNF by activating AMPK\/CREB-mediated histone acetylation","volume":"260","author":"Fang","year":"2020","journal-title":"J. Affect Disord."},{"issue":"9","key":"10.1016\/j.neubiorev.2025.106218_bib59","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1038\/s41380-018-0344-6","article-title":"New roles for dopamine D(2) and D(3) receptors in pancreatic beta cell insulin secretion","volume":"25","author":"Farino","year":"2020","journal-title":"Mol. Psychiatry"},{"issue":"3992","key":"10.1016\/j.neubiorev.2025.106218_bib60","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1126\/science.173.3992.149","article-title":"Brain serotonin content: physiological dependence on plasma tryptophan levels","volume":"173","author":"Fernstrom","year":"1971","journal-title":"Science"},{"key":"10.1016\/j.neubiorev.2025.106218_bib61","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3389\/fnut.2018.00047","article-title":"The Impact of Antidepressant Therapy on Glycemic Control in Canadian Primary Care Patients With Diabetes Mellitus","volume":"5","author":"Gagnon","year":"2018","journal-title":"Front Nutr."},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106218_bib62","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0123197","article-title":"Dopamine modulates insulin release and is involved in the survival of rat pancreatic beta cells","volume":"10","author":"Garcia Barrado","year":"2015","journal-title":"PloS One"},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106218_bib63","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.cell.2016.07.028","article-title":"Astrocytic Insulin Signaling Couples Brain Glucose Uptake with Nutrient Availability","volume":"166","author":"Garc\u00eda-C\u00e1ceres","year":"2016","journal-title":"Cell"},{"issue":"23","key":"10.1016\/j.neubiorev.2025.106218_bib64","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3390\/ijms252312631","article-title":"Efficacy and Safety of Agomelatine in Depressed Patients with Diabetes: A Systematic Review and Meta-Analysis","volume":"25","author":"G\u0119dek","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neubiorev.2025.106218_bib65","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.bbi.2020.05.013","article-title":"Protein and gene markers of metabolic dysfunction and inflammation together associate with functional connectivity in reward and motor circuits in depression","volume":"88","author":"Goldsmith","year":"2020","journal-title":"Brain Behav. Immun."},{"issue":"12","key":"10.1016\/j.neubiorev.2025.106218_bib66","doi-asserted-by":"crossref","first-page":"3992","DOI":"10.2337\/db14-0340","article-title":"Insulin regulates brain function, but how does it get there?","volume":"63","author":"Gray","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.neubiorev.2025.106218_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2019.109720","article-title":"Association between diabetes and mood disorders and the potential use of anti-hyperglycemic agents as antidepressants","volume":"95","author":"Grigolon","year":"2019","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"12","key":"10.1016\/j.neubiorev.2025.106218_bib68","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.2337\/dc16-1145","article-title":"Lifetime Duration of Depressive Disorders in Patients With Type 2 Diabetes","volume":"39","author":"de Groot","year":"2016","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.neubiorev.2025.106218_bib69","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/1440-1681.12265","article-title":"Metformin may produce antidepressant effects through improvement of cognitive function among depressed patients with diabetes mellitus","volume":"41","author":"Guo","year":"2014","journal-title":"Clin. Exp. Pharm. Physiol."},{"key":"10.1016\/j.neubiorev.2025.106218_bib70","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.physbeh.2014.02.036","article-title":"Antidepressant effects of insulin in streptozotocin induced diabetic mice: Modulation of brain serotonin system","volume":"129","author":"Gupta","year":"2014","journal-title":"Physiol. Behav."},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106218_bib71","doi-asserted-by":"crossref","DOI":"10.1111\/jne.12934","article-title":"Intranasal insulin","volume":"33","author":"Hallschmid","year":"2021","journal-title":"J. Neuroendocr."},{"issue":"3(3","key":"10.1016\/j.neubiorev.2025.106218_bib72","article-title":"2nd. Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease","volume":"9","author":"Hanson","year":"2008","journal-title":"BMC Neurosci."},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106218_bib73","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1055\/a-1351-0566","article-title":"Metformin Attenuates the Metabolic Disturbance and Depression-like Behaviors Induced by Corticosterone and Mediates the Glucose Metabolism Pathway","volume":"54","author":"Hao","year":"2021","journal-title":"Pharmacopsychiatry"},{"issue":"5","key":"10.1016\/j.neubiorev.2025.106218_bib74","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1001\/archpsyc.57.5.503","article-title":"Evidence of the dual mechanisms of action of venlafaxine","volume":"57","author":"Harvey","year":"2000","journal-title":"Arch. Gen. Psychiatry"},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106218_bib75","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jdiacomp.2003.11.001","article-title":"A randomised trial of insulin on well-being and carer strain in elderly type 2 diabetic subjects","volume":"18","author":"Hendra","year":"2004","journal-title":"J. Diabetes Complicat."},{"key":"10.1016\/j.neubiorev.2025.106218_bib76","doi-asserted-by":"crossref","unstructured":"Hennings J.M., Ising M., Grautoff S., Himmerich H., Pollm\u00e4cher T., Schaaf L. Glucose tolerance in depressed inpatients, under treatment with mirtazapine and in healthy controls. Exp Clin Endocrinol Diabetes.;118(2):98-100. doi:10.1055\/s-0029-1237361.","DOI":"10.1055\/s-0029-1237361"},{"issue":"36","key":"10.1016\/j.neubiorev.2025.106218_bib77","doi-asserted-by":"crossref","first-page":"5900","DOI":"10.2174\/138161212803523662","article-title":"Glucose metabolism and antidepressant medication","volume":"18","author":"Hennings","year":"2012","journal-title":"Curr. Pharm. Des."},{"issue":"6","key":"10.1016\/j.neubiorev.2025.106218_bib78","first-page":"1594","article-title":"Diabetes mellitus: its differentiation into insulin-sensitive and insulin-insensitive types","volume":"42","author":"Himsworth","year":"2013","journal-title":"1936. Int J. Epidemiol."},{"issue":"8","key":"10.1016\/j.neubiorev.2025.106218_bib79","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.neubiorev.2013.03.010","article-title":"Effects of diabetes on hippocampal neurogenesis: links to cognition and depression","volume":"37","author":"Ho","year":"2013","journal-title":"Neurosci. Biobehav Rev."},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106218_bib80","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.physbeh.2011.09.003","article-title":"Depressive phenotypes evoked by experimental diabetes are reversed by insulin","volume":"105","author":"Ho","year":"2012","journal-title":"Physiol. Behav."},{"issue":"12","key":"10.1016\/j.neubiorev.2025.106218_bib81","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.2337\/dc13-0234","article-title":"Effects of naltrexone sustained-release\/bupropion sustained-release combination therapy on body weight and glycemic parameters in overweight and obese patients with type 2 diabetes","volume":"36","author":"Hollander","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.neubiorev.2025.106218_bib82","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0165-0327(12)00632-5","article-title":"Dialogue on Diabetes and Depression: Dealing with the double burden of co-morbidity","volume":"142","author":"Holt","year":"2012","journal-title":"J. Affect Disord."},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106218_bib83","doi-asserted-by":"crossref","DOI":"10.1111\/eci.14122","article-title":"Changes in lipid profile and glucose metabolism following administration of bupropion alone or in combination with naltrexone: A systematic review and meta-regression analysis","volume":"54","author":"Hu","year":"2024","journal-title":"Eur. J. Clin. Invest"},{"key":"10.1016\/j.neubiorev.2025.106218_bib84","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.psychres.2017.07.076","article-title":"Association of serum BDNF levels with psychotic symptom in chronic patients with treatment-resistant depression in a Chinese Han population","volume":"257","author":"Huang","year":"2017","journal-title":"Psychiatry Res"},{"issue":"11","key":"10.1016\/j.neubiorev.2025.106218_bib85","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1007\/s00125-024-06243-z","article-title":"Association of glucagon-like peptide-1 receptor agonists with suicidal ideation and self-injury in individuals with diabetes and obesity: a propensity-weighted, population-based cohort study","volume":"67","author":"Hurtado","year":"2024","journal-title":"Diabetologia"},{"key":"10.1016\/j.neubiorev.2025.106218_bib86","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.psyneuen.2017.01.023","article-title":"Can C-reactive protein inform antidepressant medication selection in depressed outpatients? Findings from the CO-MED trial","volume":"78","author":"Jha","year":"2017","journal-title":"Psychoneuroendocrinology"},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106218_bib87","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.3448","article-title":"Dulaglutide treatment reverses depression-like behavior and hippocampal metabolomic homeostasis in mice exposed to chronic mild stress","volume":"14","author":"Jin","year":"2024","journal-title":"Brain Behav."},{"issue":"6","key":"10.1016\/j.neubiorev.2025.106218_bib88","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.psyneuen.2012.08.010","article-title":"Does pioglitazone improve depression through insulin-sensitization? Results of a randomized double-blind metformin-controlled trial in patients with polycystic ovarian syndrome and comorbid depression","volume":"38","author":"Kashani","year":"2013","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106218_bib89","first-page":"S46","article-title":"5. Lifestyle Management: Standards of Medical Care in Diabetes-2019","volume":"42","year":"2019","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106218_bib90","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/15622970902717024","article-title":"Beyond the monoaminergic hypothesis: agomelatine, a new antidepressant with an innovative mechanism of action","volume":"10","author":"Kasper","year":"2009","journal-title":"World J. Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106218_bib91","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.bbr.2005.06.031","article-title":"Effects of potassium channel inhibitors in the forced swimming test: possible involvement of L-arginine-nitric oxide-soluble guanylate cyclase pathway","volume":"165","author":"Kaster","year":"2005","journal-title":"Behav. Brain Res"},{"issue":"27","key":"10.1016\/j.neubiorev.2025.106218_bib92","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1056\/NEJMoa1003955","article-title":"Collaborative care for patients with depression and chronic illnesses","volume":"363","author":"Katon","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106218_bib93","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.jad.2011.06.033","article-title":"Use of insulin sensitizers for the treatment of major depressive disorder: a pilot study of pioglitazone for major depression accompanied by abdominal obesity","volume":"136","author":"Kemp","year":"2012","journal-title":"J. Affect Disord."},{"issue":"12","key":"10.1016\/j.neubiorev.2025.106218_bib94","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.2337\/dc20-1561","article-title":"Antidiabetes Agents and Incident Depression: A Nationwide Population-Based Study","volume":"43","author":"Kessing","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.neubiorev.2025.106218_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109293","article-title":"Canagliflozin attenuates chronic unpredictable mild stress induced neuroinflammation via modulating AMPK\/mTOR autophagic signaling","volume":"223","author":"Khedr","year":"2023","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106218_bib96","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1007\/s11096-011-9507-0","article-title":"Glucose dysregulation associated with antidepressant agents: an analysis of 17 published case reports","volume":"33","author":"Khoza","year":"2011","journal-title":"Int J. Clin. Pharm."},{"issue":"11","key":"10.1016\/j.neubiorev.2025.106218_bib97","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.1073\/pnas.1500877112","article-title":"Insulin resistance in brain alters dopamine turnover and causes behavioral disorders","volume":"112","author":"Kleinridders","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"10.1016\/j.neubiorev.2025.106218_bib98","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/pds.1608","article-title":"Influence of antidepressants on glycaemic control in patients with diabetes mellitus","volume":"17","author":"Knol","year":"2008","journal-title":"Pharmacoepidemiol Drug Saf."},{"issue":"6","key":"10.1016\/j.neubiorev.2025.106218_bib99","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.cmet.2011.03.021","article-title":"Role for insulin signaling in catecholaminergic neurons in control of energy homeostasis","volume":"13","author":"K\u00f6nner","year":"2011","journal-title":"Cell Metab."},{"issue":"7-8","key":"10.1016\/j.neubiorev.2025.106218_bib100","article-title":"Predictors of treatment response to serotonin and noradrenaline reuptake inhibitors in fibromyalgia","volume":"133","author":"Krupa","year":"2023","journal-title":"Pol. Arch. Intern Med"},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106218_bib101","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/YCO.0000000000000905","article-title":"Consolidating evidence on the role of insulin resistance in major depressive disorder","volume":"37","author":"Krupa","year":"2024","journal-title":"Curr. Opin. Psychiatry"},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106218_bib102","first-page":"42","article-title":"Sexual Functioning and Depressive Symptoms in Women with Diabetes and Prediabetes Receiving Metformin Therapy: A Pilot Study","volume":"125","author":"Krysiak","year":"2017","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"10.1016\/j.neubiorev.2025.106218_bib103","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ynstr.2016.05.001","article-title":"Pioglitazone, a PPAR\u03b3 agonist rescues depression associated with obesity using chronic unpredictable mild stress model in experimental mice","volume":"3","author":"Kurhe","year":"2016","journal-title":"Neurobiol. Stress"},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106218_bib104","doi-asserted-by":"crossref","first-page":"421","DOI":"10.4088\/JCP.v67n0313","article-title":"Effect of mirtazapine treatment on body composition and metabolism","volume":"67","author":"Laimer","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.neubiorev.2025.106218_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111734","article-title":"Pioglitazone rescues high-fat diet-induced depression-like phenotypes and hippocampal astrocytic deficits in mice","volume":"140","author":"Lam","year":"2021","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.neubiorev.2025.106218_bib106","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.neulet.2013.08.070","article-title":"Nongenomic, glucocorticoid receptor-mediated regulation of serotonin transporter cell surface expression in embryonic stem cell derived serotonergic neurons","volume":"554","author":"Lau","year":"2013","journal-title":"Neurosci. Lett."},{"issue":"5","key":"10.1016\/j.neubiorev.2025.106218_bib107","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.2337\/dc09-1515","article-title":"Undertreatment of mental health problems in adults with diagnosed diabetes and serious psychological distress: the behavioral risk factor surveillance system, 2007","volume":"33","author":"Li","year":"2010","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106218_bib108","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/s41392-022-01073-0","article-title":"Trends in insulin resistance: insights into mechanisms and therapeutic strategy","volume":"7","author":"Li","year":"2022","journal-title":"Signal Transduct. Target Ther."},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106218_bib109","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14497","article-title":"Neurological and metabolic related pathophysiologies and treatment of comorbid diabetes with depression","volume":"30","author":"Li","year":"2024","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.neubiorev.2025.106218_bib110","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.intimp.2017.05.036","article-title":"Pioglitazone attenuates lipopolysaccharide-induced depression-like behaviors, modulates NF-\u03baB\/IL-6\/STAT3, CREB\/BDNF pathways and central serotonergic neurotransmission in mice","volume":"49","author":"Liao","year":"2017","journal-title":"Int Immunopharmacol."},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106218_bib111","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.psychres.2015.10.013","article-title":"Adjuvant pioglitazone for unremitted depression: Clinical correlates of treatment response","volume":"230","author":"Lin","year":"2015","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.neubiorev.2025.106218_bib112","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109653","article-title":"The GLP-1 receptor agonist exenatide ameliorates neuroinflammation, locomotor activity, and anxiety-like behavior in mice with diet-induced obesity through the modulation of microglial M2 polarization and downregulation of SR-A4","volume":"115","author":"Lin","year":"2023","journal-title":"Int Immunopharmacol."},{"key":"10.1016\/j.neubiorev.2025.106218_bib113","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2022.113772","article-title":"Metformin alleviates the depression-like behaviors of elderly apoE4 mice via improving glucose metabolism and mitochondrial biogenesis","volume":"423","author":"Lin","year":"2022","journal-title":"Behav. Brain Res"},{"issue":"9","key":"10.1016\/j.neubiorev.2025.106218_bib114","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.2337\/db15-1737","article-title":"Cerebrovascular Safety of Sulfonylureas: The Role of KATP Channels in Neuroprotection and the Risk of Stroke in Patients With Type 2 Diabetes","volume":"65","author":"Liu","year":"2016","journal-title":"Diabetes"},{"issue":"9","key":"10.1016\/j.neubiorev.2025.106218_bib115","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1073\/pnas.1515724113","article-title":"Consumption of palatable food primes food approach behavior by rapidly increasing synaptic density in the VTA","volume":"113","author":"Liu","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106218_bib116","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01777-19","article-title":"Second-Generation Antidiabetic Sulfonylureas Inhibit Candida albicans and Candidalysin-Mediated Activation of the NLRP3 Inflammasome","volume":"64","author":"Lowes","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.neubiorev.2025.106218_bib117","article-title":"Gut Microbiota in Alzheimer's Disease, Depression, and Type 2 Diabetes Mellitus: The Role of Oxidative Stress","volume":"2019","author":"Luca","year":"2019","journal-title":"Oxid. Med Cell Longev."},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106218_bib118","doi-asserted-by":"crossref","first-page":"459","DOI":"10.2337\/dc06-1769","article-title":"Factors influencing glycemic control in type 2 diabetes during acute- and maintenance-phase treatment of major depressive disorder with bupropion","volume":"30","author":"Lustman","year":"2007","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106218_bib119","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/00006842-199705000-00007","article-title":"Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial","volume":"59","author":"Lustman","year":"1997","journal-title":"Psychosom. Med"},{"issue":"8","key":"10.1016\/j.neubiorev.2025.106218_bib120","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1001\/archgenpsychiatry.2009.86","article-title":"Altered prefrontal glutamate-glutamine-gamma-aminobutyric acid levels and relation to low cognitive performance and depressive symptoms in type 1 diabetes mellitus","volume":"66","author":"Lyoo","year":"2009","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neubiorev.2025.106218_bib121","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/6940515","article-title":"Redox Balance, Antioxidant Defense, and Oxidative Damage in the Hypothalamus and Cerebral Cortex of Rats with High Fat Diet-Induced Insulin Resistance","volume":"2018","author":"Maciejczyk","year":"2018","journal-title":"Oxid. Med Cell Longev."},{"issue":"6","key":"10.1016\/j.neubiorev.2025.106218_bib122","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1159\/000335352","article-title":"Naltrexone\/bupropion: an investigational combination for weight loss and maintenance","volume":"4","author":"Makowski","year":"2011","journal-title":"Obes. Facts"},{"issue":"11","key":"10.1016\/j.neubiorev.2025.106218_bib123","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.euroneuro.2017.08.433","article-title":"Treatment with a GLP-1R agonist over four weeks promotes weight loss-moderated changes in frontal-striatal brain structures in individuals with mood disorders","volume":"27","author":"Mansur","year":"2017","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106218_bib124","doi-asserted-by":"crossref","DOI":"10.1111\/jne.12928","article-title":"The impact of insulin on the serotonergic system and consequences on diabetes-associated mood disorders","volume":"33","author":"Martin","year":"2021","journal-title":"J. Neuroendocr."},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106218_bib125","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0306-9877(94)90075-2","article-title":"Enhancing central and peripheral insulin activity as a strategy for the treatment of endogenous depression--an adjuvant role for chromium picolinate?","volume":"43","author":"McCarty","year":"1994","journal-title":"Med Hypotheses"},{"issue":"5","key":"10.1016\/j.neubiorev.2025.106218_bib126","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1517\/14656566.6.5.707","article-title":"Duloxetine: pharmacoeconomic implications of an antidepressant that alleviates painful physical symptoms","volume":"6","author":"McIntyre","year":"2005","journal-title":"Expert Opin. Pharm."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106218_bib127","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1517\/14740338.5.1.157","article-title":"The effect of antidepressants on glucose homeostasis and insulin sensitivity: synthesis and mechanisms","volume":"5","author":"McIntyre","year":"2006","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.neubiorev.2025.106218_bib128","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.psyneuen.2018.05.010","article-title":"Repositioning of diabetes treatments for depressive symptoms: A systematic review and meta-analysis of clinical trials","volume":"94","author":"Moulton","year":"2018","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neubiorev.2025.106218_bib129","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.brainresbull.2018.09.017","article-title":"Antidepressant-like effects of insulin and IGF-1 are mediated by IGF-1 receptors in the brain","volume":"143","author":"Mueller","year":"2018","journal-title":"Brain Res Bull."},{"key":"10.1016\/j.neubiorev.2025.106218_bib130","doi-asserted-by":"crossref","DOI":"10.1007\/s00213-024-06663-0","article-title":"Empagliflozin-activated AMPK elicits neuroprotective properties in reserpine-induced depression via regulating dynamics of hippocampal autophagy\/inflammation and PKC\u03b6-mediated neurogenesis","author":"Muhammad","year":"2024","journal-title":"Psychopharmacol. (Berl. )"},{"issue":"7","key":"10.1016\/j.neubiorev.2025.106218_bib131","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s00592-023-02063-6","article-title":"Comparing sodium-glucose cotransporter 2 inhibitors and dipeptidyl peptidase-4 inhibitors on new-onset depression: a propensity score-matched study in Hong Kong","volume":"60","author":"Mui","year":"2023","journal-title":"Acta Diabetol."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106218_bib132","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.metabol.2014.09.010","article-title":"Structure, production and signaling of leptin","volume":"64","author":"M\u00fcnzberg","year":"2015","journal-title":"Metab.: Clin. Exp."},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106218_bib133","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/smi.2808","article-title":"Inhibition is associated with metabolic syndrome and depression through inflammation","volume":"34","author":"Murdock","year":"2018","journal-title":"Stress Health"},{"key":"10.1016\/j.neubiorev.2025.106218_bib134","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1146\/annurev.physiol.70.113006.100707","article-title":"Mechanisms of leptin action and leptin resistance","volume":"70","author":"Myers","year":"2008","journal-title":"Annu Rev. Physiol."},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106218_bib135","doi-asserted-by":"crossref","first-page":"387","DOI":"10.31662\/jmaj.2023-0214","article-title":"Assessing the Metabolic and Physical Effects of Combined DPP4 and SGLT2 Inhibitor Therapy in Patients with Type-2 Diabetes Mellitus: An Observational Prospective Pilot Study","volume":"7","author":"Nagayama","year":"2024","journal-title":"Jma J."},{"issue":"6","key":"10.1016\/j.neubiorev.2025.106218_bib136","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.pharep.2016.07.006","article-title":"Possible involvement of ATP-sensitive potassium channels in the antidepressant-like effect of baclofen in mouse forced swimming test","volume":"68","author":"Nazari","year":"2016","journal-title":"Pharm. Rep."},{"key":"10.1016\/j.neubiorev.2025.106218_bib137","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174602","article-title":"Saxagliptin ameliorated the depressive-like behavior induced by chronic unpredictable mild stress in rats: Impact on incretins and AKT\/PI3K pathway","volume":"912","author":"Nazeem","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neubiorev.2025.106218_bib138","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.bbi.2015.02.002","article-title":"Insufficient glucocorticoid signaling and elevated inflammation in coronary heart disease patients with comorbid depression","volume":"48","author":"Nikkheslat","year":"2015","journal-title":"Brain Behav. Immun."},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106218_bib139","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1272\/jnms.80.200","article-title":"Improving in the fasting, but not the postprandial, glucose level is associated with reduction of plasma d-ROMs level in patients with type 2 diabetes","volume":"80","author":"Ohara","year":"2013","journal-title":"J. Nippon Med Sch."},{"issue":"12","key":"10.1016\/j.neubiorev.2025.106218_bib140","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.2337\/db10-1192","article-title":"Convergence of the insulin and serotonin programs in the pancreatic \u03b2-cell","volume":"60","author":"Ohta","year":"2011","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106218_bib141","doi-asserted-by":"crossref","first-page":"49","DOI":"10.5152\/npa.2016.12373","article-title":"H. Metabolic Effects of Antidepressant Treatment","volume":"54","author":"Olguner Eker","year":"2017","journal-title":"Noro Psikiyatr Ars"},{"issue":"11","key":"10.1016\/j.neubiorev.2025.106218_bib142","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1111\/dom.12963","article-title":"Neuropsychiatric safety with liraglutide 3.0 mg for weight management: Results from randomized controlled phase 2 and 3a trials","volume":"19","author":"O'Neil","year":"2017","journal-title":"Diabetes Obes. Metab."},{"issue":"5","key":"10.1016\/j.neubiorev.2025.106218_bib143","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.dsx.2020.06.059","article-title":"Effect of sertraline in patients with newly diagnosed depression and type 2 diabetes mellitus or hypertension: An observational study from south India","volume":"14","author":"Padmapriya","year":"2020","journal-title":"Diabetes Metab. Syndr. Sep-Oct."},{"key":"10.1016\/j.neubiorev.2025.106218_bib144","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1471-2296-8-34","article-title":"Quality of life and metabolic status in mildly depressed patients with type 2 diabetes treated with paroxetine: a double-blind randomised placebo controlled 6-month trial","volume":"8","author":"Paile-Hyv\u00e4rinen","year":"2007","journal-title":"BMC Fam. Pr."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106218_bib145","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s11481-024-10142-w","article-title":"Semaglutide Attenuates Anxious and Depressive-Like Behaviors and Reverses the Cognitive Impairment in a Type 2 Diabetes Mellitus Mouse Model Via the Microbiota-Gut-Brain Axis","volume":"19","author":"de Paiva","year":"2024","journal-title":"J. Neuroimmune Pharm."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106218_bib146","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s40618-020-01260-2","article-title":"Insufficient glucocorticoid receptor signaling and flattened salivary cortisol profile are associated with metabolic and inflammatory indices in type 2 diabetes","volume":"44","author":"Panagiotou","year":"2021","journal-title":"J. Endocrinol. Investig."},{"issue":"10","key":"10.1016\/j.neubiorev.2025.106218_bib147","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000229","article-title":"Intracellular serotonin modulates insulin secretion from pancreatic beta-cells by protein serotonylation","volume":"7","author":"Paulmann","year":"2009","journal-title":"PLoS Biol."},{"key":"10.1016\/j.neubiorev.2025.106218_bib148","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.jad.2024.01.228","article-title":"Possible role of metformin as an antidepressant in diabetes","volume":"351","author":"Pedrea\u00f1ez","year":"2024","journal-title":"J. Affect Disord."},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106218_bib149","doi-asserted-by":"crossref","first-page":"665","DOI":"10.17219\/acem\/63023","article-title":"Qin YH. The relationship between major depressive disorder and glucose parameters: A cross-sectional study in a Chinese population","volume":"26","author":"Peng","year":"2017","journal-title":"Adv. Clin. Exp. Med"},{"issue":"6","key":"10.1016\/j.neubiorev.2025.106218_bib150","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12061187","article-title":"Stress and the CRH System, Norepinephrine, Depression, and Type 2 Diabetes","volume":"12","author":"Perrelli","year":"2024","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106218_bib151","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1210\/en.2011-1502","article-title":"PPAR\u03b3 agonist improves neuronal insulin receptor function in hippocampus and brain mitochondria function in rats with insulin resistance induced by long term high-fat diets","volume":"153","author":"Pipatpiboon","year":"2012","journal-title":"Endocrinology"},{"issue":"5","key":"10.1016\/j.neubiorev.2025.106218_bib152","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/ejn.12088","article-title":"DPP4-inhibitor improves neuronal insulin receptor function, brain mitochondrial function and cognitive function in rats with insulin resistance induced by high-fat diet consumption","volume":"37","author":"Pipatpiboon","year":"2013","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neubiorev.2025.106218_bib153","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/4651031","article-title":"Combined Fluoxetine and Metformin Treatment Potentiates Antidepressant Efficacy Increasing IGF2 Expression in the Dorsal Hippocampus","volume":"2019","author":"Poggini","year":"2019","journal-title":"Neural Plast."},{"key":"10.1016\/j.neubiorev.2025.106218_bib154","doi-asserted-by":"crossref","DOI":"10.1016\/j.jad.2019.05.044","volume":"257","author":"Pozzi","year":"2019","journal-title":"J. Affect Disord."},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106218_bib155","doi-asserted-by":"crossref","first-page":"194","DOI":"10.4103\/ijp.ijp_311_20","article-title":"Influence of trazodone on the pharmacodynamics and pharmacokinetics of pioglitazone","volume":"54","author":"Pradeepkumar","year":"2022","journal-title":"Indian J. Pharm."},{"issue":"5","key":"10.1016\/j.neubiorev.2025.106218_bib156","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26051940","article-title":"Agomelatine Mitigates Kidney Damage in Obese Insulin-Resistant Rats by Inhibiting Inflammation and Necroptosis via the TNF-\u03b1\/NF-\u0138B\/p-RIPK3 Pathway","volume":"26","author":"Promsan","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"11-12","key":"10.1016\/j.neubiorev.2025.106218_bib157","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00508-012-0191-4","article-title":"Hyperactivity of the hypothalamic-pituitary-adrenal axis in patients with type 2 diabetes and relations with insulin resistance and chronic complications","volume":"124","author":"Prpi\u0107-Kri\u017eevac","year":"2012","journal-title":"Wien. Klin. Woche"},{"key":"10.1016\/j.neubiorev.2025.106218_bib158","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2020.104674","article-title":"PPAR\u03b3-mediated microglial activation phenotype is involved in depressive-like behaviors and neuroinflammation in stressed C57BL\/6J and ob\/ob mice","volume":"117","author":"Qin","year":"2020","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neubiorev.2025.106218_bib159","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jad.2020.12.074","article-title":"Insulin resistance is associated with deficits in hedonic, self-reported cognitive, and psychosocial functional response to antidepressant treatment in individuals with major depressive disorder","volume":"282","author":"Rashidian","year":"2021","journal-title":"J. Affect Disord."},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106218_bib160","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1177\/02698811221132473","article-title":"Changes in insulin resistance following antidepressant treatment mediate response in major depressive disorder","volume":"37","author":"Rashidian","year":"2023","journal-title":"J. Psychopharmacol."},{"issue":"12","key":"10.1016\/j.neubiorev.2025.106218_bib161","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1590\/1806-9282.65.12.1464","article-title":"Comparison of quality of life and functionality in type 2 diabetics with and without insulin","volume":"65","author":"Reis","year":"2019","journal-title":"Rev. Assoc. Med Bras."},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106218_bib162","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.18632\/aging.202358","article-title":"Intranasal treatment of lixisenatide attenuated emotional and olfactory symptoms via CREB-mediated adult neurogenesis in mouse depression model","volume":"13","author":"Ren","year":"2021","journal-title":"Aging (Albany NY)"},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106218_bib163","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0168-8227(01)00327-8","article-title":"Insulin improves well-being for selected elderly type 2 diabetic subjects","volume":"55","author":"Reza","year":"2002","journal-title":"Diabetes Res Clin. Pr."},{"issue":"5","key":"10.1016\/j.neubiorev.2025.106218_bib164","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.diabet.2015.02.006","article-title":"Contribution of mitochondria and endoplasmic reticulum dysfunction in insulin resistance: Distinct or interrelated roles?","volume":"41","author":"Rieusset","year":"2015","journal-title":"Diabetes Metab."},{"issue":"34","key":"10.1016\/j.neubiorev.2025.106218_bib165","doi-asserted-by":"crossref","first-page":"11305","DOI":"10.1523\/JNEUROSCI.0126-10.2010","article-title":"Insulin reveals Akt signaling as a novel regulator of norepinephrine transporter trafficking and norepinephrine homeostasis","volume":"30","author":"Robertson","year":"2010","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106218_bib166","doi-asserted-by":"crossref","first-page":"420","DOI":"10.2337\/dc07-1827","article-title":"Elevated depression symptoms, antidepressant medicine use, and risk of developing diabetes during the diabetes prevention program","volume":"31","author":"Rubin","year":"2008","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106218_bib167","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/j.clnu.2018.06.966","article-title":"Time-response studies on development of cognitive deficits in an experimental model of insulin resistance","volume":"38","author":"Sachdeva","year":"2019","journal-title":"Clin. Nutr."},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106218_bib168","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqaa017","article-title":"Mitochondrial Dysfunction, Insulin Resistance, and Potential Genetic Implications","volume":"161","author":"Sangwung","year":"2020","journal-title":"Endocrinology"},{"key":"10.1016\/j.neubiorev.2025.106218_bib169","doi-asserted-by":"crossref","DOI":"10.1177\/11795514221090244","article-title":"Hyperinsulinemia Associated Depression","volume":"15","author":"Sarwar","year":"2022","journal-title":"Clin. Med Insights Endocrinol. Diabetes"},{"key":"10.1016\/j.neubiorev.2025.106218_bib170","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.nbd.2012.06.001","article-title":"Neuroreceptor imaging in depression","volume":"52","author":"Savitz","year":"2013","journal-title":"Neurobiol. Dis."},{"issue":"8","key":"10.1016\/j.neubiorev.2025.106218_bib171","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14897","article-title":"Mitochondrial plasticity and synaptic plasticity crosstalk; in health and Alzheimer's disease","volume":"30","author":"Sayehmiri","year":"2024","journal-title":"CNS Neurosci. Ther."},{"issue":"9","key":"10.1016\/j.neubiorev.2025.106218_bib172","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1073\/pnas.0308724101","article-title":"Role for neuronal insulin resistance in neurodegenerative diseases","volume":"101","author":"Schubert","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"10.1016\/j.neubiorev.2025.106218_bib173","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s40265-015-0347-4","article-title":"Depression in type 2 diabetes mellitus: prevalence, impact, and treatment","volume":"75","author":"Semenkovich","year":"2015","journal-title":"Drugs"},{"key":"10.1016\/j.neubiorev.2025.106218_bib174","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.bbi.2020.12.020","article-title":"Linking atypical depression and insulin resistance-related disorders via low-grade chronic inflammation: Integrating the phenotypic, molecular and neuroanatomical dimensions","volume":"93","author":"Sen","year":"2021","journal-title":"Brain Behav. Immun."},{"issue":"9","key":"10.1016\/j.neubiorev.2025.106218_bib175","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1038\/npp.2012.58","article-title":"Pioglitazone adjunctive therapy for moderate-to-severe major depressive disorder: randomized double-blind placebo-controlled trial","volume":"37","author":"Sepanjnia","year":"2012","journal-title":"Neuropsychopharmacology"},{"issue":"10","key":"10.1016\/j.neubiorev.2025.106218_bib176","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.4088\/JCP.09r05346blu","article-title":"Antidepressants and body weight: a comprehensive review and meta-analysis","volume":"71","author":"Serretti","year":"2010","journal-title":"J. Clin. Psychiatry"},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106218_bib177","doi-asserted-by":"crossref","first-page":"197","DOI":"10.4196\/kjpp.2015.19.3.197","article-title":"Effect of sulfonylureas administered centrally on the blood glucose level in immobilization stress model","volume":"19","author":"Sharma","year":"2015","journal-title":"Korean J. Physiol. Pharm."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106218_bib178","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0022-3565(24)38905-0","article-title":"Bupropion is a nicotinic antagonist","volume":"295","author":"Slemmer","year":"2000","journal-title":"J. Pharm. Exp. Ther."},{"issue":"40","key":"10.1016\/j.neubiorev.2025.106218_bib179","doi-asserted-by":"crossref","first-page":"6087","DOI":"10.2174\/1381612822666160922165706","article-title":"Intestinal Dysbiosis, Gut Hyperpermeability and Bacterial Translocation: Missing Links Between Depression, Obesity and Type 2 Diabetes","volume":"22","author":"Slyepchenko","year":"2016","journal-title":"Curr. Pharm. Des."},{"issue":"8","key":"10.1016\/j.neubiorev.2025.106218_bib180","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1007\/s00210-020-01838-w","article-title":"Impact of some oral hypoglycemic agents on type 2 diabetes-associated depression and reserpine-induced depression in rats: the role of brain oxidative stress and inflammation","volume":"393","author":"Soliman","year":"2020","journal-title":"Naunyn Schmiede Arch. Pharm."},{"key":"10.1016\/j.neubiorev.2025.106218_bib181","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.neuroscience.2015.05.072","article-title":"Impairment of insulin receptor substrate 1 signaling by insulin resistance inhibits neurite outgrowth and aggravates neuronal cell death","volume":"301","author":"Song","year":"2015","journal-title":"Neuroscience"},{"issue":"12","key":"10.1016\/j.neubiorev.2025.106218_bib182","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1038\/s41380-018-0086-5","article-title":"Gut microbiota modulate neurobehavior through changes in brain insulin sensitivity and metabolism","volume":"23","author":"Soto","year":"2018","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106218_bib183","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1038\/s41467-017-02221-9","article-title":"Brain insulin resistance impairs hippocampal synaptic plasticity and memory by increasing GluA1 palmitoylation through FoxO3a","volume":"8","author":"Spinelli","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neubiorev.2025.106218_bib184","doi-asserted-by":"crossref","first-page":"496","DOI":"10.3389\/fendo.2018.00496","article-title":"Links Between Obesity-Induced Brain Insulin Resistance, Brain Mitochondrial Dysfunction, and Dementia","volume":"9","author":"Sripetchwandee","year":"2018","journal-title":"Front Endocrinol. (Lausanne)"},{"issue":"9","key":"10.1016\/j.neubiorev.2025.106218_bib185","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1111\/dom.15141","volume":"25","author":"Stefanakis","year":"2023","journal-title":"Diabetes Obes. Metab."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106218_bib186","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s12974-017-0985-4","article-title":"Antidiabetic drug glyburide modulates depressive-like behavior comorbid with insulin resistance","volume":"14","author":"Su","year":"2017","journal-title":"J. Neuroinflamm."},{"issue":"5","key":"10.1016\/j.neubiorev.2025.106218_bib187","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1016\/j.apsb.2023.03.010","article-title":"Neuron stem cell NLRP6 sustains hippocampal neurogenesis to resist stress-induced depression","volume":"13","author":"Tang","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106218_bib188","doi-asserted-by":"crossref","first-page":"256","DOI":"10.2174\/18715303113139990037","article-title":"Cognitive and functional influences of vildagliptin, a DPP-4 inhibitor, added to ongoing metformin therapy in elderly with type 2 diabetes","volume":"13","author":"Tasci","year":"2013","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"key":"10.1016\/j.neubiorev.2025.106218_bib189","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.brainresbull.2021.06.011","article-title":"The effects of glucagon-like peptide 1 receptor agonist (exenatide) on memory impairment, and anxiety- and depression-like behavior induced by REM sleep deprivation","volume":"174","author":"Turan","year":"2021","journal-title":"Brain Res Bull."},{"key":"10.1016\/j.neubiorev.2025.106218_bib190","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.bbi.2020.10.025","article-title":"Increased serum peripheral C-reactive protein is associated with reduced brain barriers permeability of TSPO radioligands in healthy volunteers and depressed patients: implications for inflammation and depression","volume":"91","author":"Turkheimer","year":"2021","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neubiorev.2025.106218_bib191","doi-asserted-by":"crossref","DOI":"10.1001\/jamainternmed.2024.4369","article-title":"GLP-1 Receptor Agonist Use and Risk of Suicide Death","author":"Ueda","year":"2024","journal-title":"JAMA Intern Med"},{"issue":"11","key":"10.1016\/j.neubiorev.2025.106218_bib192","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1210\/me.2012-1226","article-title":"Dopamine synthesis and D3 receptor activation in pancreatic \u03b2-cells regulates insulin secretion and intracellular [Ca(2+)] oscillations","volume":"26","author":"Ustione","year":"2012","journal-title":"Mol. Endocrinol."},{"issue":"12","key":"10.1016\/j.neubiorev.2025.106218_bib193","doi-asserted-by":"crossref","first-page":"4186","DOI":"10.2337\/db14-0849","article-title":"GLP-1 receptor activation modulates appetite- and reward-related brain areas in humans","volume":"63","author":"Van Bloemendaal","year":"2014","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106218_bib194","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S2213-8587(19)30405-X","article-title":"Cerebral microvascular complications of type 2 diabetes: stroke, cognitive dysfunction, and depression","volume":"8","author":"Van Sloten","year":"2020","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.neubiorev.2025.106218_bib195","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/105828","article-title":"Inflammation and Oxidative Stress: The Molecular Connectivity between Insulin Resistance, Obesity, and Alzheimer's Disease","volume":"2015","author":"Verdile","year":"2015","journal-title":"Mediat. Inflamm."},{"issue":"8","key":"10.1016\/j.neubiorev.2025.106218_bib196","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/dme.14042","article-title":"Prevalence of comorbid major depressive disorder in Type 2 diabetes: a meta-analysis of comparative and epidemiological studies","volume":"36","author":"Wang","year":"2019","journal-title":"Diabet. Med"},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106218_bib197","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.bpsgos.2023.08.008","article-title":"Toward a precision treatment approach for metabolic depression: integrating epidemiology, neuroscience, and psychiatry","volume":"3","author":"Watson","year":"2023","journal-title":"Biol. Psychiatry Glob. Open Sci."},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106218_bib198","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1007\/s40615-023-01619-0","article-title":"Impact of race and ethnicity on severe hypoglycemia associated with sulfonylurea use for type 2 diabetes among veterans","volume":"11","author":"Weeda","year":"2024","journal-title":"J. Racial Ethn. Health Disparities"},{"issue":"11","key":"10.1016\/j.neubiorev.2025.106218_bib199","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1017\/S0033291724001053","article-title":"Shared familial risk for type 2 diabetes mellitus and psychiatric disorders: a nationwide multigenerational genetics study","volume":"54","author":"Wimberley","year":"2024","journal-title":"Psychol. Med"},{"key":"10.1016\/j.neubiorev.2025.106218_bib200","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2022.105715","article-title":"Diabetes, antidiabetic medications and risk of depression - a population-based cohort and nested case-control study","volume":"140","author":"Wium-Andersen","year":"2022","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neubiorev.2025.106218_bib201","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jad.2016.06.018","article-title":"Association of treatment response with obesity and other metabolic risk factors in adults with depressive disorders: results from a National Depression Cohort study in Korea (the CRESCEND study)","volume":"203","author":"Woo","year":"2016","journal-title":"J. Affect Disord."},{"key":"10.1016\/j.neubiorev.2025.106218_bib202","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/719076","article-title":"Insulin resistance-associated interhemispheric functional connectivity alterations in T2DM: a resting-state fMRI study","volume":"2015","author":"Xia","year":"2015","journal-title":"Biomed. Res Int"},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106218_bib203","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1007\/s11682-019-00049-z","article-title":"Alterations in effective connectivity within the Papez circuit are correlated with insulin resistance in T2DM patients without mild cognitive impairment","volume":"14","author":"Xia","year":"2020","journal-title":"Brain Imaging Behav."},{"key":"10.1016\/j.neubiorev.2025.106218_bib204","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.918852","article-title":"Neurotrophic Factor-\u03b11\/carboxypeptidase E functions in neuroprotection and alleviates depression","volume":"15","author":"Xiao","year":"2022","journal-title":"Front Mol. Neurosci."},{"issue":"11","key":"10.1016\/j.neubiorev.2025.106218_bib205","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13267","article-title":"PPAR\u03b3 agonists delay age-associated metabolic disease and extend longevity","volume":"19","author":"Xu","year":"2020","journal-title":"Aging Cell"},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106218_bib206","doi-asserted-by":"crossref","DOI":"10.3390\/nu15010038","article-title":"Glucagon-like peptide 1 receptor activation inhibits microglial pyroptosis via promoting mitophagy to alleviate depression-like behaviors in diabetic mice","volume":"15","author":"Yang","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.neubiorev.2025.106218_bib207","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112837","article-title":"Metformin modulates microbiota-derived inosine and ameliorates methamphetamine-induced anxiety and depression-like withdrawal symptoms in mice","volume":"149","author":"Yang","year":"2022","journal-title":"Biomed. Pharm."},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106218_bib208","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/WNR.0000000000001401","article-title":"Effects of metformin on lipopolysaccharide-induced depressive-like behavior in mice and its mechanisms","volume":"31","author":"Yang","year":"2020","journal-title":"Neuroreport"},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106218_bib209","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.cell.2015.02.047","article-title":"Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis","volume":"161","author":"Yano","year":"2015","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.neubiorev.2025.106218_bib210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021551","article-title":"Metabolic effects of fluoxetine in adults with type 2 diabetes mellitus: a meta-analysis of randomized placebo-controlled trials","volume":"6","author":"Ye","year":"2011","journal-title":"PloS One"},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106218_bib211","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nrn1883","article-title":"The therapeutic potential of monoamine oxidase inhibitors","volume":"7","author":"Youdim","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"issue":"12","key":"10.1016\/j.neubiorev.2025.106218_bib212","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.2337\/dc16-2053","article-title":"Psychosocial care for people with diabetes: a position statement of the American diabetes association","volume":"39","author":"Young-Hyman","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.neubiorev.2025.106218_bib213","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jad.2022.09.015","article-title":"Association of metformin and depression in patients with type 2 diabetes","volume":"318","author":"Yu","year":"2022","journal-title":"J. Affect Disord."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106218_bib214","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s12888-024-05627-0","article-title":"Efficacy of empagliflozin as adjunctive therapy to citalopram in major depressive disorder: a randomized double-blind, placebo-controlled clinical trial","volume":"24","author":"Zandifar","year":"2024","journal-title":"BMC Psychiatry"},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106218_bib215","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/da.22340","article-title":"Pioglitazone adjunctive therapy for depressive episode of bipolar disorder: a randomized, double-blind, placebo-controlled trial","volume":"32","author":"Zeinoddini","year":"2015","journal-title":"Depress Anxiety"},{"issue":"30","key":"10.1016\/j.neubiorev.2025.106218_bib216","doi-asserted-by":"crossref","first-page":"5935","DOI":"10.1523\/JNEUROSCI.2904-18.2019","article-title":"Metformin promotes anxiolytic and antidepressant-like responses in insulin-resistant mice by decreasing circulating branched-chain amino acids","volume":"39","author":"Zemdegs","year":"2019","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2025.106218_bib217","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3389\/fnmol.2017.00293","article-title":"Rosiglitazone exerts an anti-depressive effect in unpredictable chronic mild-stress-induced depressive mice by maintaining essential neuron autophagy and inhibiting excessive astrocytic apoptosis","volume":"10","author":"Zhao","year":"2017","journal-title":"Front Mol. Neurosci."},{"issue":"10","key":"10.1016\/j.neubiorev.2025.106218_bib218","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1210\/me.2014-1120","article-title":"Repurposing cAMP-modulating medications to promote \u03b2-cell replication","volume":"28","author":"Zhao","year":"2014","journal-title":"Mol. Endocrinol."},{"issue":"10","key":"10.1016\/j.neubiorev.2025.106218_bib219","doi-asserted-by":"crossref","first-page":"e1248","DOI":"10.4088\/JCP.15m10154","article-title":"Increased dipeptidyl peptidase-4 activity is associated with high prevalence of depression in middle-aged and older adults: a cross-sectional study","volume":"77","author":"Zheng","year":"2016","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.neubiorev.2025.106218_bib220","article-title":"Mechanisms of gut microbiota-immune-host interaction on glucose regulation in type 2 diabetes","volume":"14","author":"Zhou","year":"2023","journal-title":"Front Microbiol"},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106218_bib221","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000488367","article-title":"Changes in gene expression profiles in adult rat brain structures after neonatal action of dipeptidyl peptidase-IV inhibitors","volume":"76","author":"Zubkov","year":"2017","journal-title":"Neuropsychobiology"}],"container-title":["Neuroscience &amp; Biobehavioral Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763425002180?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763425002180?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T14:32:00Z","timestamp":1749652320000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149763425002180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":221,"alternative-id":["S0149763425002180"],"URL":"https:\/\/doi.org\/10.1016\/j.neubiorev.2025.106218","relation":{},"ISSN":["0149-7634"],"issn-type":[{"value":"0149-7634","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insulin resistance: The role in comorbid type 2 diabetes mellitus and depression","name":"articletitle","label":"Article Title"},{"value":"Neuroscience & Biobehavioral Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neubiorev.2025.106218","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106218"}}